This brand name is authorized in Brazil, Cyprus, Ecuador, Estonia, Spain, Hong Kong, Croatia, Lithuania, Poland, Romania
The drug NEPHROTECT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
L-isoleucine
UNII 04Y7590D77 - ISOLEUCINE
|
|
|
|
2
L-leucine
UNII GMW67QNF9C - LEUCINE
|
|
|
|
3
Lysine acetate
UNII K3Z4F929H6 - LYSINE
|
|
|
|
4
Methionine
UNII AE28F7PNPL - METHIONINE
|
|
|
|
5
L-phenylalanine
UNII 47E5O17Y3R - PHENYLALANINE
|
|
|
|
6
L-threonine
UNII 2ZD004190S - THREONINE
|
|
|
|
7
L-tryptophane
UNII 8DUH1N11BX - TRYPTOPHAN
|
|
|
|
8
Valine
UNII E88E0XVI4M - 3',5'-L-VALINYL-L-DEOXYCYTIDINE
|
|
|
|
9
L-Arginine
UNII 94ZLA3W45F - ARGININE
|
|
Arginine is an essential amino acid that is physiologically active in the L-form. It is commonly found as a component of total parenteral nutrition. |
|
10
L-histidine
UNII 4QD397987E - HISTIDINE
|
|
|
|
11
L-Alanine
UNII OF5P57N2ZX - ALANINE
|
|
The alanine is an a-amino acid and the L-stereoisomer is one of the 24 protein amino acids encoded by the human genetic code. The a-carbon of alanine is a methyl group (-CH3). Based on this characteristic, alanine is classified as “non-polar” or “hydrophobic” amino acid. Also the methyl alanine is relatively chemically inert, which means that the alanine almost never involved in the functionality of the proteins, but is usually a structural part of the proteins, without being part of the “active site” of them. |
|
12
Cysteine
UNII WYQ7N0BPYC - ACETYLCYSTEINE
|
|
|
|
13
Glycine
UNII TE7660XO1C - GLYCINE
|
|
|
|
14
Proline
UNII 9DLQ4CIU6V - PROLINE
|
|
|
|
15
L-serine
UNII 452VLY9402 - SERINE
|
|
|
|
16
L-tyrosine
UNII 42HK56048U - TYROSINE
|
|
|
|
17
Glycine
UNII TE7660XO1C - GLYCINE
|
|
|
|
18
Tyrosine
UNII 42HK56048U - TYROSINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05BA01 | Amino acids | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 509507901156414, 509507904155419, 509520070027507, 509520070027607 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 7315-MEE-0622 |
| Country: EE | Ravimiamet | Identifier(s): 1137260, 1137271 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 67038 |
| Country: HK | Department of Health Drug Office | Identifier(s): 65651 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1012947, 1012948 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100087966 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W43118001, W43118002, W43118003, W43118004 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
